{"id":1796,"date":"2017-07-25T07:00:20","date_gmt":"2017-07-25T07:00:20","guid":{"rendered":"http:\/\/rushmore.wpcolorlab.com\/?page_id=4"},"modified":"2022-03-24T14:12:04","modified_gmt":"2022-03-24T14:12:04","slug":"inmnoterapia-contra-el-cancer","status":"publish","type":"page","link":"https:\/\/oncovix.mpois.com\/","title":{"rendered":"Inmunoterapia contra el c\u00e1ncer"},"content":{"rendered":"<p><section data-kc-fullwidth=\"content\" class=\"kc-elm kc-css-513832 kc_row\"><div class=\"kc-row-container\"><div class=\"kc-wrap-columns\"><div class=\"kc-elm kc-css-572913 kc_col-sm-12 kc_column kc_col-sm-12\"><div class=\"kc-col-container\"><div class=\"sabbi-site-head\"><div class=\"sabbi-site-header-meta kc-elm kc-css-305001 kc-animated kc-animate-eff-fadeInDown\" >\n            <div class=\"site-hmsl-content text-center pt_60\">\n                <div class=\"seq seq--kawsa\" id=\"sequence\" data-slideautoPlay=\"\" data-slideautoPlayInterval=\"3000\">\n                    <div class=\"seq-screen\">\n                        <ul class=\"seq-canvas\"><li class=\"seq-step1\" id=\"step1\" style=\"background-image:url(https:\/\/oncovix.mpois.com\/wp-content\/uploads\/2021\/08\/inmunoterapia.jpg)\">\n                                <div class=\"bg-blend\"><\/div>\n                                <div class=\"seq-content\" ><h2 class=\"seq-title tt_up\" data-seq=\"\">Inmunoterapia contra el C\u00e1ncer <\/h2><div class=\"seq-meta\" data-seq=\"\">\n                                            <p class=\"seq-meta-text\">Programa de inmunoterapia inmunogenica antitumoral<\/p>\n                                        <\/div><a href=\"https:\/\/oncovix.mpois.com\/?page_id=275\" title=\"\" target=\"_self\" class=\"btn-link btn-more\">Leer M\u00e1s<\/a><\/div>\n                            <\/li><li class=\"seq-step1\" id=\"step2\" style=\"background-image:url(https:\/\/oncovix.mpois.com\/wp-content\/uploads\/2021\/08\/inmunoterapia-1024x400-1.jpg)\">\n                                <div class=\"bg-blend\"><\/div>\n                                <div class=\"seq-content\" ><div class=\"seq-meta\" data-seq=\"\">\n                                            <p class=\"seq-meta-text\">\u2022Oncovix \u00ae\ufe0f desarrollado desde USA, con aplicacion cl\u00ednica local en cada pa\u00eds de Iberoam\u00e9rica, por equipo profesional entrenado. <br>\r\n\u2022Oncovix \u00ae\ufe0f seleccionado y presentado en 2nd International Conference on Immunity and Immunochemistry, Barcelona, Espa\u00f1a 2021. Etapas de desarrollo molecular de Oncovix\u00ae\ufe0f contaron con apoyo y fondos de programas CORFO-CHILE e IncubaUDEC.<br>\r\n\u2022Oncovix \u00ae\ufe0f es exclusiva biotecnolog\u00eda personalizada bajo admisi\u00f3n, para cobertura particular-privada o de polizas de seguro de inmunoterapia adoptiva. Pa\u00edses de latino\u00e1m\u00e9rica a\u00fan no incorporan cobertura universal para Inmunoterapia adoptiva 3a generaci\u00f3n personalizada (Sin cobertura por salud p\u00fablica, obra social, seguridad social, mutuaria, FES, Fonasa, Isapres, GES, AUGE, IMSS, ISSSTE, EPS, ARS , etc)<\/p>\n                                        <\/div><a href=\"https:\/\/oncovix.mpois.com\/?page_id=2559\" title=\"PROGRAMA ONCOVIX \u2013 Inmunoterapia CANCER\" target=\"_blank\" class=\"btn-link btn-more\">Leer M\u00e1s<\/a><\/div>\n                            <\/li><li class=\"seq-step1\" id=\"step3\" style=\"background-image:url(https:\/\/oncovix.mpois.com\/wp-content\/uploads\/2021\/08\/GettyImages-657045846.jpg)\">\n                                <div class=\"bg-blend\"><\/div>\n                                <div class=\"seq-content\" ><h2 class=\"seq-title tt_up\" data-seq=\"\">Equipo a tu servicio <\/h2><div class=\"seq-meta\" data-seq=\"\">\n                                            <p class=\"seq-meta-text\">A nivel mundial, la inmunoterapia posee s\u00f3lida evidencia y resultados favorables, disponible a nivel privado.<\/p>\n                                        <\/div><a href=\"https:\/\/oncovix.mpois.com\/rushmore_event\/late-night-barbecue-party-in-sea-beach\/\" title=\"\" target=\"_self\" class=\"btn-link btn-more\">Leer M\u00e1s<\/a><\/div>\n                            <\/li><li class=\"seq-step1\" id=\"step4\" style=\"background-image:url(https:\/\/oncovix.mpois.com\/wp-content\/uploads\/2017\/08\/Sin-titulo.png)\">\n                                <div class=\"bg-blend\"><\/div>\n                                <div class=\"seq-content\" ><h2 class=\"seq-title tt_up\" data-seq=\"\">inmunoterapia<\/h2><div class=\"seq-meta\" data-seq=\"\">\n                                            <p class=\"seq-meta-text\">inmunoterapia<\/p>\n                                        <\/div><a href=\"https:\/\/oncovix.mpois.com\/rushmore_event\/late-night-barbecue-party-in-sea-beach\/\" title=\"\" target=\"_self\" class=\"btn-link btn-more\">inmunoterapia<\/a><\/div>\n                            <\/li><\/ul>\n                        <div class=\"sec-navigate-wrap pos-y_center\">\n                            <button type=\"button\" class=\"seq-next\"><\/button>\n                            <button type=\"button\" class=\"seq-prev\"><\/button>\n                        <\/div>\n                    <\/div>\n                <\/div>\n            <\/div>\n        <\/div>\n        <\/div><\/div><\/div><\/div><\/div><\/section><section class=\"kc-elm kc-css-658670 kc_row\"><div class=\"kc-row-container  kc-container\"><div class=\"kc-wrap-columns\"><div class=\"kc-elm kc-css-480353 kc_col-sm-3 kc_column kc_col-sm-3\"><div class=\"kc-col-container\"> <article class=\"sabbi-thumlinepost-card solitude-bg__x kc-elm kc-css-965692\"><figure class=\"sabbi-thumlinepost-card-figure\">\n                           <img loading=\"lazy\" decoding=\"async\" width=\"271\" height=\"211\" src=\"https:\/\/oncovix.mpois.com\/wp-content\/uploads\/2018\/09\/hans-reniers-746177-unsplash.jpg\" class=\"img-responsive img-thumpost\" alt=\"\" \/>\n                          <\/figure><div class=\"sabbi-thumlinepost-card-meta\">\n                        <h2 class=\"info-box-title ht-5\">Oncovix de gestionado via ONCOCIT<\/h2><p>Para ONCOCIT su principal \u00e9xito, no son cifras comerciales, sino haber resuelto el desconocimiento que rodea este tipo de avances, alcanzando despu\u00e9s de a\u00f1os.<\/p>\n<a href=\"https:\/\/oncovix.mpois.com\/?page_id=2228\" title=\"Historia\" target=\"_self\" class=\"btn btn-unsolemn btn-action read-more\">Leer M\u00e1s<\/a><\/div>\n                <\/article><\/div><\/div><div class=\"kc-elm kc-css-232516 kc_col-sm-3 kc_column kc_col-sm-3\"><div class=\"kc-col-container\"> <article class=\"sabbi-thumlinepost-card solitude-bg__x kc-elm kc-css-506235\"><figure class=\"sabbi-thumlinepost-card-figure\">\n                           <img loading=\"lazy\" decoding=\"async\" width=\"271\" height=\"211\" src=\"https:\/\/oncovix.mpois.com\/wp-content\/uploads\/2021\/08\/asd.jpg\" class=\"img-responsive img-thumpost\" alt=\"\" \/>\n                          <\/figure><div class=\"sabbi-thumlinepost-card-meta\">\n                        <h2 class=\"info-box-title ht-5\">Multic\u00e9ntrico internacional<\/h2><p>Monitoreo global de programa: A cargo de OGRD Consortium, \u00fanico y \u00faltimo responsable excluyente, de toda situaci\u00f3n comercial-cl\u00ednico-legal referida a cada programa operativizado por ONCOCIT LLC USA<\/p>\n<a href=\"https:\/\/oncovix.mpois.com\/?page_id=2233\" title=\"Modelo de atenci\u00f3n\" target=\"_self\" class=\"btn btn-unsolemn btn-action read-more\">Leer M\u00e1s<\/a><\/div>\n                <\/article><\/div><\/div><div class=\"kc-elm kc-css-400603 kc_col-sm-3 kc_column kc_col-sm-3\"><div class=\"kc-col-container\"> <article class=\"sabbi-thumlinepost-card solitude-bg__x kc-elm kc-css-997006\"><figure class=\"sabbi-thumlinepost-card-figure\">\n                           <img loading=\"lazy\" decoding=\"async\" width=\"271\" height=\"211\" src=\"https:\/\/oncovix.mpois.com\/wp-content\/uploads\/2021\/08\/GettyImages-657045846-1.jpg\" class=\"img-responsive img-thumpost\" alt=\"\" \/>\n                          <\/figure><div class=\"sabbi-thumlinepost-card-meta\">\n                        <h2 class=\"info-box-title ht-5\">El modelo internacional<\/h2><p>El modelo internacional de atenci\u00f3n, posee un alto perfil inclusivo, que no limita el acceso solo a pacientes que cercanos a alg\u00fan centro de atenci\u00f3n.<br \/>\nTodos los pacientes tienen un est\u00e1ndar de igualdad.<\/p>\n<a href=\"https:\/\/oncovix.mpois.com\/?page_id=2230\" title=\"Modelo de atenci\u00f3n\" target=\"_self\" class=\"btn btn-unsolemn btn-action read-more\">Leer M\u00e1s<\/a><\/div>\n                <\/article><\/div><\/div><div class=\"kc-elm kc-css-243559 kc_col-sm-3 kc_column kc_col-sm-3\"><div class=\"kc-col-container\"> <article class=\"sabbi-thumlinepost-card solitude-bg__x kc-elm kc-css-80570\"><figure class=\"sabbi-thumlinepost-card-figure\">\n                           <img loading=\"lazy\" decoding=\"async\" width=\"271\" height=\"211\" src=\"https:\/\/oncovix.mpois.com\/wp-content\/uploads\/2018\/09\/ousa-chea-552189-unsplash.jpg\" class=\"img-responsive img-thumpost\" alt=\"\" \/>\n                          <\/figure><div class=\"sabbi-thumlinepost-card-meta\">\n                        <h2 class=\"info-box-title ht-5\">Respaldos<\/h2><p>Conozca nuestro respaldo biotecnol\u00f3gico y difusi\u00f3n que incluyen medios cient\u00edficos, acad\u00e9micos y medios digitales todo esto de la mano de resultados y testimonios de miles de pacientes.<\/p>\n<a href=\"https:\/\/oncovix.mpois.com\/?p=1615\" title=\"Respaldo\" target=\"_self\" class=\"btn btn-unsolemn btn-action read-more\">Leer M\u00e1s<\/a><\/div>\n                <\/article><\/div><\/div><\/div><\/div><\/section><section class=\"kc-elm kc-css-907892 kc_row\"><div class=\"kc-row-container  kc-container\"><div class=\"kc-wrap-columns\"><div class=\"kc-elm kc-css-985278 kc_col-sm-4 kc_column kc_col-sm-4\"><div class=\"kc-col-container\"> <article class=\"sabbi-thumlinepost-card solitude-bg__x kc-elm kc-css-966942\">\n                    <h2 class=\"entry-title ht-4\">Beneficios de la inmunoterapia<\/h2>\n                    <div class=\"sabbi-thumlinepost-card-meta\">\n                        <\/p>\n<p>\nEstos tratamientos se toleran muy bien y el paciente es capaz de mantener esa calidad de vida que tenia previamente sin deterioro, por otra parte, el gran paradigma de la inmunoterapia es la capacidad de conseguir una prolongaci\u00f3n sustancial de la supervivencia del paciente que a veces excede de muchos meses y a veces de a\u00f1os, aspectos que no hemos visto previamente con ning\u00fan otro tipo de tratamiento en el \u00e1rea de la oncolog\u00eda.<\/p>\n<p>\n\n                        <a href=\"https:\/\/oncovix.mpois.com\/?p=1615\" title=\"Respaldo\" target=\"_self\" class=\"btn btn-unsolemn btn-action read-more\">Leer M\u00e1s<\/a>\n                    <\/div>\n                <\/article><\/div><\/div><div class=\"kc-elm kc-css-479687 kc_col-sm-4 kc_column kc_col-sm-4\"><div class=\"kc-col-container\"><article class=\"sabbi-thumlinepost-card card-video solitude-bg__x kc-elm kc-css-817745\">\n                        <figure class=\"sabbi-thumlinepost-card-figure\">\n                            <a class=\"video-play\" href=\"https:\/\/youtu.be\/OjSpTdQbJMI\" data-toggle=\"lightbox\"><img loading=\"lazy\" decoding=\"async\" width=\"1238\" height=\"892\" src=\"https:\/\/oncovix.mpois.com\/wp-content\/uploads\/2021\/08\/Captura-2.jpg\" class=\"img-responsive img-thumpost\" alt=\"\" srcset=\"https:\/\/oncovix.mpois.com\/wp-content\/uploads\/2021\/08\/Captura-2.jpg 1238w, https:\/\/oncovix.mpois.com\/wp-content\/uploads\/2021\/08\/Captura-2-300x216.jpg 300w, https:\/\/oncovix.mpois.com\/wp-content\/uploads\/2021\/08\/Captura-2-1024x738.jpg 1024w, https:\/\/oncovix.mpois.com\/wp-content\/uploads\/2021\/08\/Captura-2-768x553.jpg 768w\" sizes=\"(max-width: 1238px) 100vw, 1238px\" \/><\/a>\n                            <figcaption>Dr. Ider - Dr. Castillo<\/figcaption>\n                        <\/figure><h3 class=\"entry-title\"><a href=\"#\" target=\"_self\"><\/a><\/h3><p>Para batallar el c\u00e1ncer debe haber aproximaci\u00f3n multidisciplinar, no puede estar solo el onc\u00f3logo,  deben estar \u00e1reas como la oncolog\u00eda molecular.<\/p>\n<\/article><\/div><\/div><div class=\"kc-elm kc-css-587474 kc_col-sm-4 kc_column kc_col-sm-4\"><div class=\"kc-col-container\"><article class=\"news-card sabbi-thumlinepost-card solitude-bg__x kc-elm kc-css-829071\"><h2 class=\"stage-title\">Opciones Terap\u00e9uticas para c\u00e1ncer <\/h2><ul class=\"list-unstyled lst_news_list\" tabindex=\"0\"><li class=\"lst_news_item\">\n                        <h3 class=\"title mg_0\"><a href=\"https:\/\/oncovix.mpois.com\/?event=tratamientos-disponibles\">Tratamientos disponibles<\/a><\/h3>\n                        <div>\n                            <span class=\"date\"><\/span>\n                        <\/div>\n                    <\/li><li class=\"lst_news_item\">\n                        <h3 class=\"title mg_0\"><a href=\"https:\/\/oncovix.mpois.com\/?event=opciones-de-tratamiento\">Opciones de tratamiento<\/a><\/h3>\n                        <div>\n                            <span class=\"date\"><\/span>\n                        <\/div>\n                    <\/li><li class=\"lst_news_item\">\n                        <h3 class=\"title mg_0\"><a href=\"https:\/\/oncovix.mpois.com\/?event=que-es-el-cancer\">\u00bfQu\u00e9 es el c\u00e1ncer?<\/a><\/h3>\n                        <div>\n                            <span class=\"date\"><\/span>\n                        <\/div>\n                    <\/li><\/ul><a href=\"https:\/\/oncovix.mpois.com\/?page_id=257\" title=\"Events\" target=\"_blank\" class=\"btn btn-unsolemn btn-action read-more\">Ver M\u00e1s<\/a><\/article><\/div><\/div><\/div><\/div><\/section><section class=\"kc-elm kc-css-990209 kc_row\"><div class=\"kc-row-container  kc-container\"><div class=\"kc-wrap-columns\"><div class=\"kc-elm kc-css-618794 kc_col-sm-4 kc_column kc_col-sm-4\"><div class=\"kc-col-container\"> <div class=\"brand_quickfact-content text-center kc-elm kc-css-732315\">\n                    <div class=\"brand_quickfact-count_value\">+42.000<\/div>\n                    <div class=\"brand_quickfact-label\">Art\u00edculos que avalan Inmunoterapia<\/div>\n                <\/div><\/div><\/div><div class=\"kc-elm kc-css-516267 kc_col-sm-4 kc_column kc_col-sm-4\"><div class=\"kc-col-container\"> <div class=\"brand_quickfact-content text-center kc-elm kc-css-282684\">\n                    <div class=\"brand_quickfact-count_value\">+300<\/div>\n                    <div class=\"brand_quickfact-label\">Centros que imparten Globalmente inmunoterapia<\/div>\n                <\/div><\/div><\/div><div class=\"kc-elm kc-css-450841 kc_col-sm-4 kc_column kc_col-sm-4\"><div class=\"kc-col-container\"> <div class=\"brand_quickfact-content text-center kc-elm kc-css-17974\">\n                    <div class=\"brand_quickfact-count_value\">+4.000<\/div>\n                    <div class=\"brand_quickfact-label\"> Aplicaciones anuales<\/div>\n                <\/div><\/div><\/div><\/div><\/div><\/section><section class=\"kc-elm kc-css-515522 kc_row\"><div class=\"kc-row-container  kc-container\"><div class=\"kc-wrap-columns\"><div class=\"kc-elm kc-css-979786 kc_col-sm-4 kc_column kc_col-sm-4\"><div class=\"kc-col-container\">\n<div class=\"kc-elm kc-css-893822 kc-title-wrap \">\n\n\t<h2 class=\"kc_title\">LITERATURA CIENTIFICA DE RESPALDO EN ONCOLOGIA MOLECULAR E INMUNOTERAPIA<\/h2>\n<\/div>\n<div class=\"kc-elm kc-css-989681 kc_text_block\"><\/p>\n<p>\n<u>INMUNOTERAPIA ADOPTIVA (basada en c\u00e9lulas dendr\u00edticas)<\/u><\/p>\n<p>Destacada en distintas publicaciones por ser 1 de las 3 inmunoterapias (junto a T-CAR e inhibidores de checkpoints) con mayor respaldo, as\u00ed como alta precisi\u00f3n, personalizada, de m\u00ednimas reacciones adversas y de costo m\u00e1s accesible en comparaci\u00f3n a otras inmunoterapias. Ver p\u00e1g. 20, cr\u00e9ditos a REVISTA: \u201cInvestigaci\u00f3n y Ciencia, especial de INMUNOTERAPIA CONTRA EL CANCER, 2018<br \/><a href=\"https:\/\/www.investigacionyciencia.es\/revistas\/especial\/inmunoterapia-contra-el-cncer-748\" target=\"_blank\" rel=\"noopener\">Pulsar para ver M\u00e1s<\/a>.<\/p>\n<p>\n<\/div><a href=\"https:\/\/oncovix.mpois.com\/?page_id=505\" title=\"\" target=\"_blank\" class=\"btn btn-unsolemn btn-action read-more kc-elm kc-css-495726\">Ver toda la literatura<\/a><\/div><\/div><div class=\"kc-elm kc-css-876212 kc_col-sm-8 kc_column kc_col-sm-8\"><div class=\"kc-col-container\"><div class=\"paper_cut kc-elm kc-css-306658\"><div class=\"pub-item with-icon\">\n                    <div class=\"elem-wrapper\">\n                        <i class=\"ion-ios-paper-outline\"><\/i>\n                    <\/div>\n                    <div class=\"content-wrapper\">\n                        <h3 class=\"title mb_0\">Integrating Next-Generation Dendritic Cell Vaccines into the Current Cancer Immunotherapy Landscape.:<\/h3>\n                        <div class=\"slc_des\">\n                            <div class=\"authr\">Abhishek D. Garg\r\nPierre G. Coulie\r\nBenoit J. Van den Eynde\r\nPatrizia Agostinis\r\n<\/div>\n                        <\/div>\n                        <div class=\"description\">\n                            <a class=\"link-with-icon\" href=\"https:\/\/www.cell.com\/trends\/immunology\/fulltext\/S1471-4906(17)30094-7?_returnURL=https%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS1471490617300947%3Fshowall%3Dtrue\" target=\"black\"><i class=\"ion-ios-browsers-outline\"><\/i>Ver articulo publicado<\/a>\n                        <\/div>\n                  \n                <\/div>\n            <\/div><div class=\"pub-item with-icon\">\n                    <div class=\"elem-wrapper\">\n                        <i class=\"ion-ios-paper-outline\"><\/i>\n                    <\/div>\n                    <div class=\"content-wrapper\">\n                        <h3 class=\"title mb_0\">Dendritic Cells: The Tools for Cancer Treatment:<\/h3>\n                        <div class=\"slc_des\">\n                            <div class=\"authr\">By Hanne Locy, Sarah Melhaoui, Sarah K. Maenhout and Kris Thielemans<\/div>\n                        <\/div>\n                        <div class=\"description\">\n                            <a class=\"link-with-icon\" href=\"https:\/\/www.intechopen.com\/books\/dendritic-cells\/dendritic-cells-the-tools-for-cancer-treatment\" target=\"black\"><i class=\"ion-ios-browsers-outline\"><\/i>Ver articulo publicado<\/a>\n                        <\/div>\n                  \n                <\/div>\n            <\/div><div class=\"pub-item with-icon\">\n                    <div class=\"elem-wrapper\">\n                        <i class=\"ion-ios-paper-outline\"><\/i>\n                    <\/div>\n                    <div class=\"content-wrapper\">\n                        <h3 class=\"title mb_0\">Enhancing Dendritic Cell Therapy in Solid Tumors with Immunomodulating Conventional Treatment (2019):<\/h3>\n                        <div class=\"slc_des\">\n                            <div class=\"authr\">Robert A. Belderbos,1,2 Joachim G.J.V. Aerts,1,2 and Heleen Vroman1,2<\/div>\n                        <\/div>\n                        <div class=\"description\">\n                            <a class=\"link-with-icon\" href=\"https:\/\/www.cell.com\/molecular-therapy-family\/oncolytics\/pdfExtended\/S2372-7705(19)30037-3\" target=\"black\"><i class=\"ion-ios-browsers-outline\"><\/i>Ver articulo publicado<\/a>\n                        <\/div>\n                  \n                <\/div>\n            <\/div><\/div><\/div><\/div><\/div><\/div><\/section><\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Inmunoterapia contra el c\u00e1ncer - Oncovix<\/title>\n<meta name=\"description\" content=\"ONCOVIX es un programa de inmunoterapia inmunogenica antitumoral, Terapia adoptiva, cuya pauta incluye pauta de dise\u00f1o.Inmunoterapia contra el c\u00e1ncer\" \/>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Inmunoterapia contra el c\u00e1ncer - Oncovix\" \/>\n<meta property=\"og:description\" content=\"ONCOVIX es un programa de inmunoterapia inmunogenica antitumoral, Terapia adoptiva, cuya pauta incluye pauta de dise\u00f1o.Inmunoterapia contra el c\u00e1ncer\" \/>\n<meta property=\"og:url\" content=\"https:\/\/oncovix.mpois.com\/\" \/>\n<meta property=\"og:site_name\" content=\"Oncovix\" \/>\n<meta property=\"article:modified_time\" content=\"2022-03-24T14:12:04+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/oncovix.mpois.com\/wp-content\/uploads\/2021\/08\/inmunoterapia-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"500\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/oncovix.mpois.com\/\",\"url\":\"https:\/\/oncovix.mpois.com\/\",\"name\":\"Inmunoterapia contra el c\u00e1ncer - Oncovix\",\"isPartOf\":{\"@id\":\"https:\/\/oncovix.mpois.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/oncovix.mpois.com\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/oncovix.mpois.com\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/oncovix.mpois.com\/wp-content\/uploads\/2018\/09\/hans-reniers-746177-unsplash.jpg\",\"datePublished\":\"2017-07-25T07:00:20+00:00\",\"dateModified\":\"2022-03-24T14:12:04+00:00\",\"description\":\"ONCOVIX es un programa de inmunoterapia inmunogenica antitumoral, Terapia adoptiva, cuya pauta incluye pauta de dise\u00f1o.Inmunoterapia contra el c\u00e1ncer\",\"breadcrumb\":{\"@id\":\"https:\/\/oncovix.mpois.com\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/oncovix.mpois.com\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/oncovix.mpois.com\/#primaryimage\",\"url\":\"https:\/\/oncovix.mpois.com\/wp-content\/uploads\/2018\/09\/hans-reniers-746177-unsplash.jpg\",\"contentUrl\":\"https:\/\/oncovix.mpois.com\/wp-content\/uploads\/2018\/09\/hans-reniers-746177-unsplash.jpg\",\"width\":271,\"height\":211},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/oncovix.mpois.com\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Portada\",\"item\":\"https:\/\/oncovix.mpois.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Inmunoterapia contra el c\u00e1ncer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/oncovix.mpois.com\/#website\",\"url\":\"https:\/\/oncovix.mpois.com\/\",\"name\":\"Oncovix\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/oncovix.mpois.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/oncovix.mpois.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/oncovix.mpois.com\/#organization\",\"name\":\"Oncovix\",\"url\":\"https:\/\/oncovix.mpois.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/oncovix.mpois.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/oncovix.mpois.com\/wp-content\/uploads\/2021\/08\/logo3.jpeg\",\"contentUrl\":\"https:\/\/oncovix.mpois.com\/wp-content\/uploads\/2021\/08\/logo3.jpeg\",\"width\":1125,\"height\":349,\"caption\":\"Oncovix\"},\"image\":{\"@id\":\"https:\/\/oncovix.mpois.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Inmunoterapia contra el c\u00e1ncer - Oncovix","description":"ONCOVIX es un programa de inmunoterapia inmunogenica antitumoral, Terapia adoptiva, cuya pauta incluye pauta de dise\u00f1o.Inmunoterapia contra el c\u00e1ncer","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"es_ES","og_type":"article","og_title":"Inmunoterapia contra el c\u00e1ncer - Oncovix","og_description":"ONCOVIX es un programa de inmunoterapia inmunogenica antitumoral, Terapia adoptiva, cuya pauta incluye pauta de dise\u00f1o.Inmunoterapia contra el c\u00e1ncer","og_url":"https:\/\/oncovix.mpois.com\/","og_site_name":"Oncovix","article_modified_time":"2022-03-24T14:12:04+00:00","og_image":[{"width":1280,"height":500,"url":"https:\/\/oncovix.mpois.com\/wp-content\/uploads\/2021\/08\/inmunoterapia-1.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/oncovix.mpois.com\/","url":"https:\/\/oncovix.mpois.com\/","name":"Inmunoterapia contra el c\u00e1ncer - Oncovix","isPartOf":{"@id":"https:\/\/oncovix.mpois.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/oncovix.mpois.com\/#primaryimage"},"image":{"@id":"https:\/\/oncovix.mpois.com\/#primaryimage"},"thumbnailUrl":"https:\/\/oncovix.mpois.com\/wp-content\/uploads\/2018\/09\/hans-reniers-746177-unsplash.jpg","datePublished":"2017-07-25T07:00:20+00:00","dateModified":"2022-03-24T14:12:04+00:00","description":"ONCOVIX es un programa de inmunoterapia inmunogenica antitumoral, Terapia adoptiva, cuya pauta incluye pauta de dise\u00f1o.Inmunoterapia contra el c\u00e1ncer","breadcrumb":{"@id":"https:\/\/oncovix.mpois.com\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/oncovix.mpois.com\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/oncovix.mpois.com\/#primaryimage","url":"https:\/\/oncovix.mpois.com\/wp-content\/uploads\/2018\/09\/hans-reniers-746177-unsplash.jpg","contentUrl":"https:\/\/oncovix.mpois.com\/wp-content\/uploads\/2018\/09\/hans-reniers-746177-unsplash.jpg","width":271,"height":211},{"@type":"BreadcrumbList","@id":"https:\/\/oncovix.mpois.com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Portada","item":"https:\/\/oncovix.mpois.com\/"},{"@type":"ListItem","position":2,"name":"Inmunoterapia contra el c\u00e1ncer"}]},{"@type":"WebSite","@id":"https:\/\/oncovix.mpois.com\/#website","url":"https:\/\/oncovix.mpois.com\/","name":"Oncovix","description":"","publisher":{"@id":"https:\/\/oncovix.mpois.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/oncovix.mpois.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/oncovix.mpois.com\/#organization","name":"Oncovix","url":"https:\/\/oncovix.mpois.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/oncovix.mpois.com\/#\/schema\/logo\/image\/","url":"https:\/\/oncovix.mpois.com\/wp-content\/uploads\/2021\/08\/logo3.jpeg","contentUrl":"https:\/\/oncovix.mpois.com\/wp-content\/uploads\/2021\/08\/logo3.jpeg","width":1125,"height":349,"caption":"Oncovix"},"image":{"@id":"https:\/\/oncovix.mpois.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/oncovix.mpois.com\/index.php?rest_route=\/wp\/v2\/pages\/1796"}],"collection":[{"href":"https:\/\/oncovix.mpois.com\/index.php?rest_route=\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/oncovix.mpois.com\/index.php?rest_route=\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/oncovix.mpois.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/oncovix.mpois.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1796"}],"version-history":[{"count":14,"href":"https:\/\/oncovix.mpois.com\/index.php?rest_route=\/wp\/v2\/pages\/1796\/revisions"}],"predecessor-version":[{"id":2579,"href":"https:\/\/oncovix.mpois.com\/index.php?rest_route=\/wp\/v2\/pages\/1796\/revisions\/2579"}],"wp:attachment":[{"href":"https:\/\/oncovix.mpois.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1796"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}